Ratings of experimental pain and pain-related negative affect predict clinical pain in patients with fibromyalgia syndrome

Pain

Volumn 105, Issue 1-2, 2003, Pages 215-222

  Staud, Roland ^a   Robinson, Michael E ^a   Vierck Jr , Charles J ^a   Cannon, Richard C ^a   Mauderli, Andre P ^a   Price, Donald D ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Chronic pain intensity; Fibromyalgia; Muscle; Predictor; Temporal summation

Indexed keywords

ABDOMINAL PAIN; ADULT; AFFECT; ARTICLE; CONTROLLED STUDY; FEMALE; FIBROMYALGIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; PREDICTION; PRIORITY JOURNAL; RATING SCALE; REGRESSION ANALYSIS; SCORING SYSTEM; THERMAL STIMULATION; VISUAL ANALOG SCALE;

EID: 0141738725     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(03)00208-2     Document Type: Article

References (70)

1. Almay B.G. Clinical characteristics of patients with idiopathic pain syndromes. Depressive symptomatology and patient pain drawings. Pain. 29:1987;335-346.
2. Arendt-Nielsen L., Petersen-Felix S. Wind-up and neuroplasticity: is there a correlation to clinical pain? Eur J Anaesthesiol Suppl. 10:1995;1-7.
3. Arroyo J.F., Cohen M.L. Abnormal responses to electrocutaneous stimulation in fibromyalgia. J Rheumatol. 20:1993;1925-1931.
4. Basbaum A.I. Distinct neurochemical features of acute and persistent pain. Proc Natl Acad Sci USA. 96:1999;7739-7743.
5. Bengtsson M., Bengtsson A., Jorfeldt L. Diagnostic epidural opioid blockade in primary fibromyalgia at rest and during exercise. Pain. 39:1989;171-180.
6. Bennett G.J. Update on the neurophysiology of pain transmission and modulation: focus on the NMDA-receptor. J Pain Symptom Manage. 19:2000;S2-S6.
7. Berglund B., Harju E.L., Kosek E., Lindblom U. Quantitative and qualitative perceptual analysis of cold dysesthesia and hyperalgesia in fibromyalgia. Pain. 96:2002;177-187.
8. Bradley L.A., Alarcon G.S., Sotolongo A., Weigent D.A., Alberts K.R., Blalock J.E., Kersh B.C., Domino M.L., De Waal D. Cerebrospinal fluid (CSF) levels of substance P (SP) are abnormal in patients with fibromyalgia (FM) regardless of traumatic or insidious pain onset. Arthritis Rheum. 41:1998;S256.
9. Budai D., Larson A.A. Role of substance P in the modulation of C-fiber-evoked responses of spinal dorsal horn neurons. Brain Res. 710:1996;197-203.
10. Burckhardt C.S., Clark S.R., Bennett R.M. A comparison of pain perceptions in women with fibromyalgia and rheumatoid arthritis: relationship to depression and pain extent. Arthritis Care Res. 5:1992;216-222.
11. Croft P., Schollum J., Silman A. Population study of tender point counts and pain as evidence of fibromyalgia. Br Med J. 309:1994;696-699.
12. Croft P.R., Burt J., Schollum J., Thomas E., Macfarlane G., Silman A. More pain, more tender points: is fibromyalgia just one end of a continuous spectrum? Ann Rheum Dis. 55:1996;482-485.
13. Croft P.R., Schollum J., Silman A. Population study of tender point counts and pain as evidence of fibromyalgia. Br Med J. 309:1994;696-699.
14. Dickenson A.H., Sullivan A.F. Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C fibre stimulation. Neuropharmacology. 26:1987;1235-1238.
15. Dickenson A.H., Sullivan A.F. NMDA receptors and central hyperalgesic states. Pain. 46:1991;344-346.
16. Dubner R., Sharav Y., Gracely R.H., Price D.D. Idiopathic trigeminal neuralgia: sensory features and pain mechanisms. Pain. 31:1987;23-33.
17. Gaskin M.E., Greene A.F., Robinson M.E., Geisser M.E. Negative affect and the experience of chronic pain. J Psychosom Res. 36:1992;707-713.
18. Geisser M.E., Robinson M.E., Keefe F.J., Weiner M.L. Catastrophizing, depression and the sensory, affective and evaluative aspects of chronic pain. Pain. 59:1994;79-83.
19. Granges G., Littlejohn G. Pressure pain threshold in pain-free subjects, in patients with chronic regional pain syndromes, and in patients with fibromyalgia syndrome. Arthritis Rheum. 36:1993;642-646.
20. Graven-Nielsen T., Aspegren-Kendall S., Henriksson K.G., Bengtsson M., Sorensen J., Johnson A., Gerdle B., Arendt-Nielsen L. Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients. Pain. 85:2000;483-491.
21. Hewett J.E., Buckelew S.P., Johnson J.C., Shaw S.E., Huyser B., Fu Y.Z. Selection of measures suitable for evaluating change in fibromyalgia clinical trials. J Rheumatol. 22:1995;2307-2312.
22. Jacobs J.W., Rasker J.J., van der Heide A., Boersma J.W., de Blecourt A.C., Griep E.N., van Rijswijk M.H., Bijlsma J.W. Lack of correlation between the mean tender point score and self-reported pain in fibromyalgia. Arthritis Care Res. 9:1996;105-111.
23. Jensen B., Wittrup I.H., Rogind H., Danneskiold-Samsoe B., Bliddal H. Correlation between tender points and the fibromyalgia impact questionnaire. J Musculoskelet Pain. 8:2000;19-29.
24. Jensen K., Andersen H.O., Olesen J., Lindblom U. Pressure-pain threshold in human temporal region. Evaluation of a new pressure algometer. Pain. 25:1986;313-323.
25. Keefe F.J., Wilkins R.H., Cook W.A.J., Crisson J.E., Muhlbaier L.H. Depression, pain, and pain behavior. J Consult Clin Psychol. 54:1986;665-669.
26. Kellstein D.E., Price D.D., Hayes R.L., Mayer D.J. Evidence that substance P selectively modulates C-fiber-evoked discharges of dorsal horn nociceptive neurons. Brain Res. 526:1990;291-298.
27. Kosek E., Ekholm J., Hansson P. Increased pressure pain sensibility in fibromyalgia patients is located deep to the skin but not restricted to muscle tissue. Pain. 63:1995;335-339.
28. Kosek E., Ekholm J., Nordemar R. A comparison of pressure pain thresholds in different tissues and body regions. Long-term reliability of pressure algometry in healthy volunteers. Scand J Rehabil Med. 25:1993;117-124.
29. Larson A.A., Giovengo S.L., Russell I.J., Michalek J.E. Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: implications for nitric oxide pathways. Pain. 87:2000;201-211.
30. Lautenschlager J., Bruckle W., Schnorrenberger C.C., Muller W. Measuring pressure pain of tendons and muscles in healthy probands and patients with generalized tendomyopathy (fibromyalgia syndrome). Z Rheumatol. 47:1988;397-404.
31. Li J., Simone D.A., Larson A.A. Windup leads to characteristics of central sensitization. Pain. 79:1999;75-82.
32. Lundberg G., Gerdle B. Tender point scores and their relations to signs of mobility, symptoms, and disability in female home care personnel and the prevalence of fibromyalgia syndrome. J Rheumatol. 29:2002;603-613.
33. Malt E.A., Olafsson S., Lund A., Ursin H. Factors explaining variance in perceived pain in women with fibromyalgia. BMC Musculoskelet Disord. 3:2002;12-20.
34. Mannion R.J., Woolf C.J. Pain mechanisms and management: a central perspective. Clin J Pain. 16:2000;S144-S156.
35. McBeth J., Macfarlane G.J., Benjamin S., Morris S., Silman A.J. The association between tender points, psychological distress, and adverse childhood experiences: a community-based study. Arthritis Rheum. 42:1999;1397-1404.
36. Mendell L.M. Physiological properties of unmyelinated fiber projection to the spinal cord. Exp Neurol. 16:1966;316-332.
37. Mikkelsson M., Latikka P., Kautiainen H., Isomeri R., Isomaki H. Muscle and bone pressure pain threshold and pain tolerance in fibromyalgia patients and controls. Arch Phys Med Rehabil. 73:1992;814-818.
38. Nicassio P.M., Weisman M.H., Schuman C., Young C.W. The role of generalized pain and pain behavior in tender point scores in fibromyalgia. J Rheumatol. 27:2000;1056-1062.
39. Ohrbach R., Gale E.N. Pressure pain thresholds in normal muscles: reliability, measurement effects, and topographic differences. Pain. 37:1989;257-263.
40. Ohrbach R., Gale E.N. Pressure pain thresholds, clinical assessment, and differential diagnosis: reliability and validity in patients with myogenic pain. Pain. 39:1989;157-169.
41. Price D.D. Characteristics of second pain and flexion reflexes indicative of prolonged central summation. Exp Neurol. 37:1972;371-387.
42. Price D.D., Bennett G.J., Rafii A. Psychophysical observations on patients with neuropathic pain relieved by a sympathetic block. Pain. 36:1989;273-288.
43. Price D.D., Hayes R.L., Ruda M., Dubner R. Spatial and temporal transformations of input to spinothalamic tract neurons and their relation to somatic sensations. J Neurophysiol. 41:1978;933-947.
44. Price D.D., Hu J.W., Dubner R., Gracely R.H. Peripheral suppression of first pain and central summation of second pain evoked by noxious heat pulses. Pain. 3:1977;57-68.
45. Price D.D., Long S., Huitt C. Sensory testing of pathophysiological mechanisms of pain in patients with reflex sympathetic dystrophy. Pain. 49:1992;163-173.
46. Price D.D., Mao J., Frenk H., Mayer D.J. The N-methyl-D-aspartate receptor antagonist dextromethorphan selectively reduces temporal summation of second pain in man. Pain. 59:1994;165-174.
47. Price D.D., Mao J., Mayer D.J. Central neural mechanisms of normal and abnormal pain states. Fields H.L., Liebeskind J.C. Pharmacological approaches to the treatment of pain: new concepts and critical issues. vol. 1:1994;61-84 IASP Press, Seattle, WA.
48. Price D.D., McGrath P.A., Rafii A., Buckingham B. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain. 17:1983;45-56.
49. Price D.D., Staud R., Robinson M.E., Mauderli A.P., Cannon R.L., Vierck C.J. Jr. Enhanced temporal summation of second pain and its central modulation in fibromyalgia patients. Pain. 99:2002;49-59.
50. Quimby L.G., Block S.R., Gratwick G.M. Fibromyalgia: generalized pain intolerance and manifold symptom reporting. J Rheumatol. 15:1988;1264-1270.
51. Riley J.L., Robinson M.E., Price D.D. The stages of pain processing across the adult lifespan. J Pain. 1:2000;162-170.
52. Robinson M.E., Riley J.L. The role of emotion in pain. Gatchel R.J., Turk D.C. Psychosocial factors in pain. 1998;74-89 Guilford Press, New York, NY.
53. Russell I.J., Fletcher E.M., Vipraio G.A., Lopez Y., Orry M.A. Cerebrospinal fluid (CSF) substance P (SP) in fibromyalgia (FMS): changes in CSP SP over time parallel changes in clinical activity. Arthritis Rheum. 41:1998;S256.
54. Salt T.E., Hill R.G. Neurotransmitter candidates of somatosensory primary afferent fibres. Neuroscience. 10:1983;1083-1103.
55. Salt T.E., Morris R., Hill R.G. Distribution of substance P-responsive and nociceptive neurones in relation to substance P-immunoreactivity within the caudal trigeminal nucleus of the rat. Brain Res. 273:1983;217-228.
56. Simms R.W., Goldenberg D.L., Felson D.T., Mason J.H. Tenderness in 75 anatomic sites. Distinguishing fibromyalgia patients from controls. Arthritis Rheum. 31:1988;182-187.
57. Staud R., Cannon R.C., Mauderli A.P., Robinson M.E., Price D.D., Vierck C.J. Temporal summation of pain from mechanical stimulation of muscle tissue in normal controls and subjects with fibromyalgia syndrome. Pain. 102:2003;87-95.
58. Staud R., Robinson M.E., Vierck C.J., Price D.D. Diffuse noxious inhibitory controls (DNIC) attenuate temporal summation of second pain in normal males but not in normal females or fibromyalgia patients. Pain. 101:2003;167-174.
59. Staud R., Vierck C.J., Cannon R.L., Mauderli A.P., Price D.D. Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain. 91:2001;165-175.
60. Strittmatter M., Grauer M., Isenberg E., Hamann G., Fischer C., Hoffmann K.H., Blaes F., Schimrigk K. Cerebrospinal fluid neuropeptides and monoaminergic transmitters in patients with trigeminal neuralgia. Headache. 37:1997;211-216.
61. Torebjork H.E., Hallin R.G. Identification of afferent C units in intact human skin nerves. Brain Res. 67:1974;387-403.
62. Tunks E., Crook J., Norman G., Kalaher S. Tender points in fibromyalgia. Pain. 34:1988;11-19.
63. Vierck C.J. Jr, Staud R., Price D.D., Cannon R.L., Mauderli A.P., Martin A.D. The effect of maximal exercise on temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. J Pain. 2:2001;334-344.
64. Vierck C.J. Jr, Cannon R.L., Fry G., Maixner W., Whitsel B.L. Characteristics of temporal summation of second pain sensations elicited by brief contact of glabrous skin by a preheated thermode. J Neurophysiol. 78:1997;992-1002.
65. Von Euler U.S. The history of substance P. Bousfield D. Neurotransmitters in action. 1985;143-150 Elsevier Biomedical Press, New York, NY.
66. Wade J.B., Dougherty L.M., Archer C.R., Price D.D. Assessing the stages of pain processing: a multivariate analytical approach. Pain. 68:1996;157-167.
67. Wolfe F. The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic. Ann Rheum Dis. 56:1997;268-271.
68. Wolfe F., Russell I.J., Vipraio G., Ross K., Anderson J. Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population. J Rheumatol. 24:1997;555-559.
69. Wolfe F., Smythe H.A., Yunus M.B., Bennett R.M., Bombardier C., Goldenberg D.L., Tugwell P., Campbell S.M., Abeles M., Clark P. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 33:1990;160-172.
70. Woolf C.J., Costigan M. Transcriptional and posttranslational plasticity and the generation of inflammatory pain. Proc Natl Acad Sci USA. 96:1999;7723-7730.